MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Debt to Asset Ratio
18.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series b redeemable convertible ...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
5,500
6,375
4,473
5,230
Subscription receivable
-
0
0
0
Prepaid expenses and other current assets
563
720
428
717
Total current assets
6,063
7,095
4,901
5,947
Other assets
101
101
101
101
Total assets
6,164
7,196
5,002
6,048
Accounts payable
699
265
434
202
Accrued expenses
442
380
164
145
Total current liabilities
-
645
598
347
Royalty purchase liability
-
0
151,049
151,049
Warrant liability
-
0
0
0
Liabilities
1,141
645
151,647
151,396
Series b redeemable convertible preferred stock, 0.001 par value 10,000,000 shares authorized 119,318 shares issued and outstanding at march 31, 2026 and december 31, 2025
4,295
2,577
2,577
2,597
Common stock, 0.001 par value 200,000,000 shares authorized 75,462,390 shares issued and outstanding at march 31, 2026 and december 31, 2025
75
75
75
75
Additional paid-in capital
309,573
311,213
311,121
311,010
Accumulated deficit
-308,920
-307,314
-460,418
-459,030
Total stockholders' deficit
728
3,974
-149,222
-147,945
Total liabilities, redeemable convertible preferred stock and stockholders equity
6,164
7,196
5,002
6,048
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$5,500K Prepaid expenses andother current assets$563K Total current assets$6,063K Other assets$101K Total assets$6,164K Total liabilities,redeemable convertible...$6,164K Series b redeemableconvertible preferred...$4,295K Liabilities$1,141K Total stockholders'deficit$728K Accumulated deficit-$308,920K Accounts payable$699K Accrued expenses$442K Additional paid-in capital$309,573K Common stock, 0.001 parvalue 200,000,000...$75K

Galera Therapeutics, Inc. (GRTX)

Galera Therapeutics, Inc. (GRTX)